Sebastian Szmit, Monika Długosz-Danecka, Joanna Drozd-Sokołowska, Monika Joks, Agnieszka Szeremet, Artur Jurczyszyn, Wojciech Jurczak
BACKGROUND: Arterial hypertension is mentioned as a risk factor in Cardio-oncology. This study aimed to assess the long-term prognostic value of arterial hypertension (AH) in diffuse large B-cell lymphoma (DLBCL). METHODS: We analysed data collected by the Polish Lymphoma Research Group for the evaluation of the outcomes associated with the use of first-line rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy in patients with DLBCL with coexisting AH...
April 13, 2024: Heart, Lung & Circulation
Han Shi, Kais Hyasat, Tejas Deshmukh, Cuneyt Ada, Joseph Chiha, Kaleab Asrress, Kevin Liou
BACKGROUND: The optimal management strategy for significant unprotected ostial left anterior descending artery (LAD) disease remains undefined. Merits of the two most common percutaneous approaches are considered in this quantitative synthesis. METHOD: A meta-analysis was performed to compare ostial stenting (OS) and crossover stenting (CS) in the treatment of unprotected ostial LAD stenosis. The primary outcome is the disparity in target lesion revascularisation (TLR)...
April 12, 2024: Heart, Lung & Circulation
Giacomo Tini, Silvia Tanda, Matteo Toma, Allegra Battistoni, Beatrice Musumeci, Emanuele Barbato, Marco Canepa, Pietro Ameri
BACKGROUND: It has been postulated that cancer hampers the delivery of guideline-directed medical therapy (GDMT) for heart failure (HF). However, few data are available in this regard. METHODS: We performed a retrospective analysis from the HF Outpatient Clinic of the IRCCS Ospedale Policlinico San Martino in Genova, Italy. All HF patients evaluated between 2010 and 2019, with a left ventricular ejection fraction <50% and at least two visits ≥3 months apart with complete information about GDMT were included in the study...
April 11, 2024: Heart, Lung & Circulation
Pavithra S Jayadeva, Stacey Peters, Su Ling Tee, Luke J Burchill, Silvana F Marasco, Leeanne Grigg, Angeline Leet, David McGiffin, Dominica Zentner
BACKGROUND: Adult congenital heart disease (ACHD) services increasingly encounter heart failure (HF) in the ageing ACHD population. Optimal timing of referral for heart transplant (HTx) evaluation in this heterogeneous population is complex and ill-defined. We aim to outline the characteristics and outcomes of ACHD patients referred for HTx from a large Australian ACHD centre. METHOD: Retrospective review of ACHD patients referred for HTx from a primary ACHD centre (1992-2021)...
April 11, 2024: Heart, Lung & Circulation
Edward Wang, Paul Sadleir, Vijay Sourinathan, Rukshen Weerasooriya, David Playford, Pragnesh Joshi
AIM: To report the clinical outcomes of thoracoscopic left atrial appendage occlusion (LAAO) with the AtriClip PRO2 device (Atricure Inc, Mason, OH, USA). Stroke risk reduction with LAAO in patients with atrial fibrillation is now well-established. Many surgical and percutaneous techniques have been used, with varying rates of success. The percutaneous devices have had issues with procedural complications and peridevice flow. Thoracoscopic AtriClip offers an epicardial linear closure of the appendage at its ostium...
April 10, 2024: Heart, Lung & Circulation
Jim Pouliopoulos, Chris Anthony, Muhammad Imran, Robert M Graham, Jane McCrohon, Cameron Holloway, Eugene Kotlyar, Kavitha Muthiah, Anne M Keogh, Christopher S Hayward, Peter S Macdonald, Andrew Jabbour
BACKGROUND: Heart transplantation is an effective treatment for end-stage congestive heart failure, however, achieving the right balance of immunosuppression to maintain graft function while minimising adverse effects is challenging. Serial endomyocardial biopsies (EMBs) are currently the standard for rejection surveillance, despite being invasive. Replacing EMB-based surveillance with cardiac magnetic resonance (CMR)-based surveillance for acute cardiac allograft rejection has shown feasibility...
April 10, 2024: Heart, Lung & Circulation
Stefanos T Papageorgiou, Savvas Damdoumis, Dimitrios Goulis, Stergios Tzikas, Georgios Giannakoulas
AIM: Severe COVID-19 can cause acute respiratory distress syndrome, hypoxia, systemic complications, and increased mortality. Pulmonary hypertension (PH) is a major global health issue associated with worsening symptoms and increased mortality. This systematic review aimed to assess the influence of PH onset among COVID-19 patients on all-cause mortality and intensive care unit (ICU) admission. METHOD: An unrestricted search of five databases up to June 2022 was undertaken...
April 9, 2024: Heart, Lung & Circulation
Shalom Andugala, Amy McIntosh, Jennifer Orchard, Sarfaraz Rahiman, Anna Miedecke, Janelle Keyser, Kim Betts, Supreet Marathe, Nelson Alphonso, Prem Venugopal
BACKGROUND & AIM: Fast-track or enhanced recovery after surgery (ERAS) is a care pathway for surgical patients based on a multidisciplinary team approach aimed at optimising recovery without increasing risk with protocols based on scientific evidence, which is monitored continuously to ensure compliance and improvement. These protocols have been shown to reduce the duration of postoperative mechanical ventilation and intensive care unit (ICU) length of stay (LOS) following paediatric cardiac surgery...
April 8, 2024: Heart, Lung & Circulation
Jonathon B Ryan, Peter W Grant
BACKGROUND: Transcatheter aortic valve implantation (TAVI) did not receive regulatory approval in Australia until 2013, several years after Europe (2007) and America (2011). Consequently, the uptake of TAVI in Australia initially lagged behind international best practices. This study was undertaken to provide an update on the status of TAVI activity in Australia. METHOD: A descriptive population-level epidemiological study was performed. Annual activity data for both surgical aortic valve replacement (SAVR) and TAVI were obtained from the Australian Institute of Health and Welfare (AIHW) for the period from 1 July 2012 to 30 June 2022...
April 6, 2024: Heart, Lung & Circulation
Emma K Gard, Samer Noaman, Dion Stub, Pieter Vriesendorp, Nay Htun, Rozanne Johnston, Elisha Gartner, Ronald Dick, Antony Walton, David Kaye, Shane Nanayakkara
BACKGROUND: Patients undergoing transcatheter aortic valve implantation (TAVI) have a high comorbidity burden. We sought to stratify patients into functional outcomes using the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), a patient-reported outcome with benefits over both the New York Heart Association (NYHA) classification and the original 23-item KCCQ, and to evaluate the importance of comorbidities in predicting failure of functional improvement post-TAVI in a contemporary cohort...
April 5, 2024: Heart, Lung & Circulation
Md Shajedur Rahman Shawon, Jonathon B Ryan, Louisa Jorm
BACKGROUND: In Australia, transcatheter aortic valve implantation (TAVI) is only performed in a limited number of specialised metropolitan centres, many of which are private hospitals, making it likely that TAVI patients who require readmission will present to another (non-index) hospital. It is important to understand the impact of non-index readmission on patient outcomes and healthcare resource utilisation. METHOD: We analysed linked hospital and death records for residents of New South Wales, Australia, aged ≥18 years, who had an emergency readmission within 90 days following a TAVI procedure in 2013-2022...
April 4, 2024: Heart, Lung & Circulation
Olivia Nuti, Cristian Merchan, John Papadopoulos, James Horowitz, Sunil V Rao, Tania Ahuja
BACKGROUND: Evidence supporting anticoagulation with unfractionated heparin (UFH) in patients with an intra-aortic balloon pump (IABP) to prevent limb ischaemia remains limited, while bleeding risks remain high. Monitoring heparin in this setting with anti-factor Xa (anti-Xa) is not previously described. OBJECTIVES: The study objective is to describe the incidence of thromboembolic and bleeding events with the use of UFH in patients with an IABP utilising monitoring with both anti-Xa and activated partial thromboplastin time (aPTT)...
April 3, 2024: Heart, Lung & Circulation
Arul Baradi, Diem T Dinh, Angela Brennan, Dion Stub, Jithendra Somaratne, Sonny Palmer, Ziad Nehme, Emily Andrew, Karen Smith, Danny Liew, Christopher M Reid, Jeffrey Lefkovits, Andrew Wilson
AIM: We aim to describe prevalence of Emergency Medical Service (EMS) use, investigate factors predictive of EMS use, and determine if EMS use predicts treatment delay and mortality in our ST-elevation myocardial infarction (STEMI) cohort. METHOD: We prospectively collected data on 5,602 patients presenting with STEMI for primary percutaneous coronary intervention (PCI) transported to PCI-capable hospitals in Victoria, Australia, from 2013-2018 who were entered into the Victorian Cardiac Outcomes Registry (VCOR)...
April 2, 2024: Heart, Lung & Circulation
Mohammad Rocky Khan Chowdhury, Dion Stub, Diem Dinh, Md Nazmul Karim, Bodrun Naher Siddiquea, Baki Billah
BACKGROUND AND AIM: Risk adjustment following percutaneous coronary intervention (PCI) is vital for clinical quality registries, performance monitoring, and clinical decision-making. There remains significant variation in the accuracy and nature of risk adjustment models utilised in international PCI registries/databases. Therefore, the current systematic review aims to summarise preoperative variables associated with 30-day mortality among patients undergoing PCI, and the other methodologies used in risk adjustments...
April 2, 2024: Heart, Lung & Circulation
Stephanie R Sargent, Jordanna R Mladenovic, Jacqueline J T Liaw, Jonathan Siller, Penni L Russell, Matthew K Y Tung, David J Holland
BACKGROUND: Modifiable lifestyle risk factors, in particular obesity and related conditions, are important drivers of atrial fibrillation (AF), impacting the severity of symptoms and influence the efficacy and safety of treatment. OBJECTIVE: The study aimed to assess the impact of modifiable lifestyle factors on the effectiveness and safety of AF ablation, and examine the procedural characteristics, efficacy, safety and cost outcomes of cryoballoon vs radiofrequency ablation, in a real-world clinical setting...
April 2, 2024: Heart, Lung & Circulation
Nicole K Bart, Diane Fatkin, James Gunton, James L Hare, Dariusz Korczyk, Fiona Kwok, Kaitlyn Lam, David Russell, Hasib Sidiqi, Tim Sutton, Simon D J Gibbs, Peter Mollee, Liza Thomas
Over the past 5 years, early diagnosis of and new treatments for cardiac amyloidosis (CA) have emerged that hold promise for early intervention. These include non-invasive diagnostic tests and disease modifying therapies. Recently, CA has been one of the first types of cardiomyopathy to be treated with gene editing techniques. Although these therapies are not yet widely available to patients in Australia and New Zealand, this may change in the near future. Given the rapid pace with which this field is evolving, it is important to view these advances within the Australian and New Zealand context...
April 2, 2024: Heart, Lung & Circulation
Joseph M O'Brien, Rustem Dautov, James Sapontis
The percutaneous management of chronic total occlusions (CTO) is a well-established sub-specialty of Interventional Cardiology, requiring specialist equipment, training, and techniques. The heterogeneity of approaches in CTO has led to the generation of multiple algorithms to guide operators in their management. The evidence base for management of CTOs has suffered from inconsistent descriptive and quantitative terminology in defining the nature of lesions and techniques utilised, as well as seemingly contradictory data about improvement in ventricular function, symptoms of angina, and mortality from large-scale registries and randomised controlled trials...
April 1, 2024: Heart, Lung & Circulation
Wayne C Zheng, Nicole Evans, Diem Dinh, Jason E Bloom, Angela L Brennan, Jocasta Ball, Jeffrey Lefkovits, James A Shaw, Christopher M Reid, William Chan, Dion Stub
BACKGROUND: Clinical outcomes of patients with renal transplant (RT) undergoing percutaneous coronary intervention (PCI) remain poorly elucidated. METHOD: Between 2014 and 2021, data were analysed for the following three groups of patients undergoing PCI enrolled in a multicentre Australian registry: (1) RT recipients (n=226), (2) patients on dialysis (n=992), and (3) chronic kidney disease (CKD) patients (estimated glomerular filtration rate [eGFR], 30‒60 mL/min per 1...
April 1, 2024: Heart, Lung & Circulation
Jen-Li Looi, Aleisha Easton, Mark Webster, Andrew To, Mildred Lee, Andrew J Kerr
BACKGROUND: Recurrent Takotsubo syndrome (TS) is not uncommon but experience with TS recurrence is inherently limited by the infrequency of the condition itself and incomplete long-term follow-up. There is limited published data on the clinical features and outcomes of patients with recurrent TS. We aimed to describe the clinical characteristics and outcomes of patients with recurrent TS in a large Auckland cohort. METHOD: The clinical profile, in-hospital, and long-term outcomes were prospectively assessed in consecutive patients with recurrent TS presenting to Auckland's three major hospitals between January 2006 and January 2023...
March 29, 2024: Heart, Lung & Circulation
Wilbert Huang, Alvin Frederich, Alizha Rochana Putri
AIM: Type 4a myocardial infarction (T4aMI), defined as myocardial injury associated with percutaneous coronary intervention (PCI), is associated with a poor prognosis and there is conflicting evidence regarding the effectiveness of remote ischaemic conditioning (RIC) in its prevention. This review aimed to determine the effect of RIC on stable and unstable angina patients. METHOD: A systematic review was conducted in PubMed and Central database. Outcome measures were: changes in peak troponin, creatine kinase myocardial band (CKMB), C-reactive protein (CRP) level, incidence of T4aMI, and major adverse cardiovascular event (MACE)...
March 19, 2024: Heart, Lung & Circulation
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.